Related Experiment Video

Updated: Sep 20, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.9K

Progress toward molecular therapy for diabetes mellitus: A focus on targeting inflammatory factors

Mohadesse Dehghan1, Fateme Ghorbani2, Sajad Najafi3

  • 1Department of Microbiology, Faculity of Life Science, Islamic Azad University, North Tehran Branch, Tehran, Iran.

Diabetes Research and Clinical Practice
|June 11, 2022
PubMed

Insights

New nucleic-acid-based therapies show promise for treating diabetes mellitus (DM) by regulating gene expression and targeting inflammation, offering potential improvements over existing treatments.

Area of Science:

  • Metabolic disease research
  • Immunology
  • Molecular medicine

Background:

  • Diabetes mellitus (DM) is a prevalent metabolic disease with significant health risks.
  • Inflammation and immunity play key roles in both type 1 DM (T1DM) and type 2 DM (T2DM).
  • Current treatments for DM often fall short in maintaining euglycemia and preventing complications.

Purpose of the Study:

  • To review recent advancements in molecular therapy for DM.
  • To explore the potential of nucleic-acid-based therapies in managing DM.
  • To assess the efficacy of these therapies against inflammatory mediators in DM.

Main Methods:

  • Literature review of recent progress in DM molecular therapy.
  • Focus on nucleic-acid-based approaches and gene expression regulation.
  • Analysis of therapeutic potential against inflammatory pathways in DM.

Main Results:

  • Nucleic-acid-based therapies are emerging as promising strategies for DM.
  • These therapies offer a novel approach to target insulin resistance.
  • Potential efficacy against inflammatory mediators involved in DM pathogenesis is under investigation.

Conclusions:

  • Novel molecular therapies, particularly nucleic-acid-based ones, are needed for DM.
  • Targeting gene expression offers a promising avenue for improving DM outcomes.
  • Further research is warranted to validate the efficacy of these therapies against DM-related inflammation.
Keywords:
Diabetes MellitusInflammatory factorsMolecular Therapy

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K
Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

535

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
415
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
443
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
68
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K